Overview

Decadron as Adjuvant in Femoral Nerve Blocks in Knee Arthroscopy

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
If preservative-free dexamethasone 0.1 mg/kg (max dose 4 mg) is added to ropivacaine 0.5% 2 mg/kg (max dose 100 mg), then post-PACU opioid consumption will be reduced by 33%.
Phase:
Phase 3
Details
Lead Sponsor:
Nationwide Children's Hospital
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Ropivacaine